Divitiae Investments

Divitiae Investments officially goes LIVE Today!!!! We opened the waitlist during Diwali. Hundreds joined. Now its time to sign in. Three ready ideas waiting for you and more coming soon!!! Research-backed. Founder-led fast-grower framework. Real updates. Real conviction. Let’s build wealth, the right way. For Investor, By Investors Team Divitiae

Happy Ram Navami 🎉🎉🎉💐💐💐

Indigrid is offering 9.9% Dividend yield in case someone is interested in such product.

One month cease fire talks as reported by Israel media

Shilpa Medicare up 14%, our star performer today. Not a buy sell recommendation.

Strongest stock of 2026!! We are invested and biased in our various small cases. @Goldforestinves @AimInvestments

Crude oil down 10%

Semaglutide is set to transform diabetes & obesity care in India—but the big question is: 💉 Vials or Pens — what will patients actually prefer? We break down convenience, affordability, adherence, and real-world usage insights with Dr Unnikrishnan AG. Watch now to understand where the market is headed 👇 youtu.be/p3MNptfx-EY #Semaglutide #GLP1 #DiabetesCare #ObesityTreatment #IndianPharma #HealthcareInvesting

This is a small request from our side ❤️ Behind every video on our YouTube channel is a team that is working tirelessly… Late nights, deep research, countless hours, all to bring you the best insights in markets. If our work has ever helped you even a little 🙏 👉 Please support the team by subscribing to our YouTube channel: @DivitiaeInvestments" target="_blank" rel="nofollow noopener">youtube.com/@DivitiaeInves…

Breaking down two myths spreading on generic Semaglutide launch. Prices have dropped-> No they haven't. Generics are always launched at 60-70 or even 90% of innovator prices. The right question to ask is, are generic companies profitable at this price. Go and check margins of large generic pharma companies you will get the answer. Its a commoditized market so no one will make money-> Generic markets are always commoditized with several players but larger 80% market share typically lies with top 5-10 players. If lower price was the winner like commodity then lowest price drugs will have the biggest market share which is not the case. Because quality is more important when it comes to medicines than price.

How long patients take GLP1 drugs? What happens when they stop? Two critical questions answered in this short video by an expert Endo to help you understand the TAM. youtu.be/sEvTZmS0Xlo?si…

Understand these critical things before your invest in GLP1 theme: 👉Its a long term play +5 years, cumulative effect 👉GLP1 is not only product companies are going to sell 👉India is not the only market, +80 countries open now 👉Market will follow Pareto 80/20 rule, few winners 👉Generic pharma is crowded but few win big Talk to us if you have questions 👉divitiae.in

@AimInvestments @DivitiaeIn Dam nice it was

Remson is a Small Auto Anc with Big Customers like Lamborghini, Aston Martin & Jaguar Post recent correction it trades at attractive PE of 16.7 Join the meeting with the Promoter (direct link)-> tinyurl.com/DivitiaeRemson…

Generic Affordable Semaglutide available now but they have to be given to eligible patients by Qualified Endocrinologists or MD physicians only as per DCGI .These are not cosmetic drugs and u can’t bypass diet or resistance exercise and need strong pharmacovigilance.@IndiaESI @MoHFW_INDIA @JPNadda @ani_digital

Understand basics of GLP1 drugs from an Expert Endocrinologist youtu.be/gNqEQwwj8RI

Who will win the GLP1 Race? Watch our video clip from today’s webinar Follow our channel for more such contents youtu.be/zqdGvB4IU18?si…

Generic Semaglutide market Price vs Access Positioning

Semaglutide Launches so far today: this are price points

The webinar is live now ! Please join in : tinyurl.com/DivitiaeGLP1 direct link ( no Registration)